These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1128 related items for PubMed ID: 18849306

  • 1. Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy.
    Laurberg P, Bournaud C, Karmisholt J, Orgiazzi J.
    Eur J Endocrinol; 2009 Jan; 160(1):1-8. PubMed ID: 18849306
    [Abstract] [Full Text] [Related]

  • 2. Management of Graves' disease during pregnancy in the Poitou-Charentes Region.
    Hawken C, Sarreau M, Bernardin M, Delcourt AC, Muller A, Lefort G, Pernollet P, Marechaud R.
    Ann Endocrinol (Paris); 2016 Oct; 77(5):570-577. PubMed ID: 27375108
    [Abstract] [Full Text] [Related]

  • 3. Therapy insight: management of Graves' disease during pregnancy.
    Chan GW, Mandel SJ.
    Nat Clin Pract Endocrinol Metab; 2007 Jun; 3(6):470-8. PubMed ID: 17515891
    [Abstract] [Full Text] [Related]

  • 4. Important considerations in the management of Graves' disease in pregnant women.
    Okosieme OE, Lazarus JH.
    Expert Rev Clin Immunol; 2015 Jun; 11(8):947-57. PubMed ID: 26041458
    [Abstract] [Full Text] [Related]

  • 5. Foetal and neonatal thyroid disorders.
    Radetti G, Zavallone A, Gentili L, Beck-Peccoz P, Bona G.
    Minerva Pediatr; 2002 Oct; 54(5):383-400. PubMed ID: 12244277
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Pregnancy and the thyroid gland].
    Lieutaud H.
    Ann Med Interne (Paris); 1999 Sep; 150(5):397-407. PubMed ID: 10544750
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hyperthyroidism during pregnancy--the role of measuring maternal TSH receptor antibodies and foetal ultrasound monitoring.
    Gietka-Czernel M, Dębska M, Kretowicz P, Zgliczyński W, Ołtarzewski M.
    Endokrynol Pol; 2014 Sep; 65(4):259-68. PubMed ID: 25185847
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Treatment of hyperthyroidism due to Graves' disease: what is the recommended antithyroid drug during pregnancy?].
    Caron P.
    J Gynecol Obstet Biol Reprod (Paris); 2013 May; 42(3):232-7. PubMed ID: 23312275
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Increased size and vascularisation, plus decreased echogenicity, of foetal thyroid in two-dimensional ultrasonography caused by maternal Graves' disease.
    Gietka-Czernel M, Dębska M, Kretowicz P, Jastrzębska H, Zgliczyński W.
    Endokrynol Pol; 2014 May; 65(1):64-8. PubMed ID: 24549604
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 57.